| Literature DB >> 12901909 |
Yoshiaki Isobe1, Masanori Tobe, Haruhisa Ogita, Ayumu Kurimoto, Tetsuhiro Ogino, Hajime Kawakami, Haruo Takaku, Hironao Sajiki, Kosaku Hirota, Hideya Hayashi.
Abstract
Recently we reported the adenine derivatives (2-4) as new interferon (IFN) inducers. In the present study, we conducted a detailed structure and activity relationship study of 4 and its related derivatives on IFN inducing activity. From this study, we found that compound 4 exhibited the most potent IFN inducing activity in vitro with a minimum effective concentration of 0.01 microM, and 4 also showed strong IFN-inducing activity at doses of more than 0.3mg/kg by oral administration in mice. This potency was 10-fold stronger than that of Imiquimod. Moreover, 4 did not cause emesis in ferrets even at doses as high as 10mg/kg, whereas, 80% of animals were emetic when orally administered with the same dose of Imiquimod. These results indicate that compound 4 is superior to Imiquimod with respect to efficacy and safety.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12901909 DOI: 10.1016/s0968-0896(03)00369-9
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641